- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Amneal Pharmaceuticals Inc Class A (AMRX)
8.650
+0.100(+1.17%)
Closed
After Hours
8.500-0.150(-1.734%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.580
8.705
52 wk Range
3.360
8.940
AMRX Scorecard
Full Analysis
Net income is expected to grow this year
Amneal Pharmaceuticals Inc Class A stock price live, this page displays NASDAQ AMRX stock exchange data. View the AMRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Amneal Pharmaceuticals Inc Class A real time stock price chart below.
What Is the Amneal Pharmaceuticals Inc Class A Stock Price Today?
The Amneal Pharmaceuticals Inc Class A stock price today is 8.650.
What Is the Stock Symbol for Amneal Pharmaceuticals Inc Class A?
The stock symbol for Amneal Pharmaceuticals Inc Class A is "AMRX."
What Stock Exchange Does Amneal Pharmaceuticals Inc Class A Trade On?
Amneal Pharmaceuticals Inc Class A is listed and trades on the NASDAQ stock exchange.
Is Amneal Pharmaceuticals Inc Class A a Good Stock to Buy?
Determining whether Amneal Pharmaceuticals Inc Class A—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AMRX quote. (ISIN: US03168L1052)
What Is the Amneal Pharmaceuticals Inc Class A Stock Price Today?
The Amneal Pharmaceuticals Inc Class A stock price today is 8.650.
What Is the Stock Symbol for Amneal Pharmaceuticals Inc Class A?
The stock symbol for Amneal Pharmaceuticals Inc Class A is "AMRX."
What Stock Exchange Does Amneal Pharmaceuticals Inc Class A Trade On?
Amneal Pharmaceuticals Inc Class A is listed and trades on the NASDAQ stock exchange.
Is Amneal Pharmaceuticals Inc Class A a Good Stock to Buy?
Determining whether Amneal Pharmaceuticals Inc Class A—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AMRX quote. (ISIN: US03168L1052)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.5808.705
52 wk Range
3.3608.940
UnlockAMRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Price Target
10.000
Upside
+15.607%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
- Impax Laboratorie receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Truist maintains Buy on Amneal on new partnership
- Investing.com
- Impax Laboratorie receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Truist maintains Buy on Amneal on new partnership
- Investing.com
- Impax Laboratorie receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Amneal Pharma A Company Profile
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, and topical products. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson’s disease, and endocrine disorders. This segment also provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson’s disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid for the treatment of hypothyroidism; and IPX203, a pipeline product for Parkinson’s disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
Compare AMRX to Peers and Sector
Metrics to compare | AMRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAMRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.3x | −0.4x | −0.6x | |
PEG Ratio | 0.00 | 0.04 | 0.00 | |
Price/Book | −46.6x | 0.7x | 2.6x | |
Price / LTM Sales | 1.0x | 1.2x | 3.2x | |
Upside (Analyst Target) | 9.8% | 21.3% | 41.1% | |
Fair Value Upside | Unlock | 4.7% | 5.9% | Unlock |
FAQ
What Is the Amneal Pharma A (AMRX) Stock Price Today?
The Amneal Pharma A stock price today is 8.65.
What Stock Exchange Does Amneal Pharma A Trade On?
Amneal Pharma A is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Amneal Pharma A?
The stock symbol for Amneal Pharma A is "AMRX."
What Is the Amneal Pharma A Market Cap?
As of today, Amneal Pharma A market cap is 2.68B.
What is Amneal Pharma A Earnings Per Share?
The Amneal Pharma A EPS is -0.688.
What Is the Next Amneal Pharma A Earnings Date?
Amneal Pharma A will release its next earnings report on 06 Nov 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.